Join
Live feed
·
PRReleasevia Quantisnow
Trinity Biotech plc logo

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

ByQuantisnow·Wall Street's wire, on your screen.
TRIB· Trinity Biotech plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRIB (Trinity Biotech plc) and more on Quantisnow.